Kuoyang Sun

907 citations
11 papers · 672 indexed · 1 hit paper · h-index 10
Topics
Osteoarthritis Treatment and Mechanisms (4 papers)MXene and MAX Phase Materials (4 papers)Graphene and Nanomaterials Applications (2 papers)
Partner nations
ChinaJapanCzechia

In The Last Decade

Kuoyang Sun

11 papers receiving 667 citations

Hit Papers

TRPV1 alleviates osteoarthritis by inhibiting M1 macropha...2021202620222024202150100150

Peers

Kuoyang Sun
Comparison fields: 5 of 99
  • Molecular Biology 230
  • Biomedical Engineering 199
  • Materials Chemistry 168
  • Rheumatology 120
  • Immunology 79
Replace Zhongyang Lv with:
Zhongyang Lv China
Timo Schomann Netherlands
Jun Pan China
Yoshie Arai South Korea
Shaojingya Gao China
Mingwu Deng China
Sheila Mac Neil United Kingdom
Kuoyang Sun relative to Zhongyang Lv China Zhongyang Lv's profile →
Citations per field
00.5×1.5×
Zhongyang Lv · 1×
Citations per year

Countries citing papers authored by Kuoyang Sun

Since Specialization
Citations

This map shows the geographic impact of Kuoyang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuoyang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuoyang Sun more than expected).

Fields of papers citing papers by Kuoyang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuoyang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuoyang Sun. The network helps show where Kuoyang Sun may publish in the future.

Co-authorship network of co-authors of Kuoyang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Kuoyang Sun. A scholar is included among the top collaborators of Kuoyang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuoyang Sun. Kuoyang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 15
2 3
3 44
4 38
5 60
6 60
7
TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathwaybreakdown →
180
8 62
9 15
10 129
11 66

About Kuoyang Sun

Kuoyang Sun is a scholar working on Rehabilitation, Rheumatology and Sensory Systems, having authored 11 papers that have together received 672 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (4 papers), MXene and MAX Phase Materials (4 papers) and Graphene and Nanomaterials Applications (2 papers). The work is most often cited by research in Rheumatology (120 citations), Sensory Systems (33 citations) and Pharmaceutical Science (40 citations). Kuoyang Sun has collaborated with scholars based in China, Japan and Czechia. Frequent co-authors include Zhongyang Lv, Dongquan Shi, Ziying Sun, Rui Wu, Qing Jiang, Xingquan Xu, Jiawei Li, Hu Guo, Jia Xu and Shiro Ikegawa. Their work appears in journals such as ACS Nano, Chemical Engineering Journal and Small.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026